Biotechnology Stocks I Performance Guide: Apellis Pharmaceuticals, Inc. (APLS)
APLS has no dividends.
Table and Chart of APLS Performance
See what a $1,000 investment in APLS is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| APLS Returns | |
|---|---|
| Start Date | Dec-29-2017 |
| Start Price | $21.70 |
| End Date | Oct-15-2024 |
| End Price | $27.95 |
| # Prices | 83 |
| Min Date | Dec-31-2018 |
| Min Price | $13.19 |
| Max Date | Jun-30-2023 |
| Max Price | $91.10 |
| Total Return | 28.80% |
| Annualized Return | 3.73% |
| Current Value of $1,000 Purchase | $1,288 |
| Number Returns | 3,403 |
| Average Return | 71.98% |
| Number Profitable Returns | 2,605 |
| Percent Profitable Returns | 76.55% |
| Number Unprofitable Returns | 798 |
| Percent Unprofitable Returns | 23.45% |
| Profitable to Unprofitable Returns Ratio | 3.26 |
| APLS Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,024 |
| Beta | -12.120 | Price to Sales |
| Earnings per Share | $0.0000 |
| PE Ratio | -311300000 |
| PE to Growth Ratio | None |
| Price to Book | 5.41 |
| PRICE DATA | |
| 52 Week High | $0.867 |
| 52 Week Low | $73.8 |
| Analyst Target Price | $1.103 |
| 50-Day Moving Average | $26.28 |
| 200-Day Moving Average | $34.69 |
| FINANCIAL DATA | |
| Revenue per Share | $-2.72 |
| Revenue | $-1 |
| Profit Margin | 515% |
| Return on Equity | -21.5% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
APLS Compare Returns with S&P 500
APLS Trendline Chart
APLS Moving Average Chart
APLS Stock Return Map - See Patterns of Gains and Losses
APLS Stock Returns/Purchase Dates